Table 3.
The most commonly identified pathogens by mNGS in 121 patients∗.
| mNGS results | Immunocompromised (n = 70) | Nonimmunocompromised (n = 51) |
|---|---|---|
| Bacteria | Pseudomonas aeruginosa 9 (12.9) | Pseudomonas aeruginosa 4 (7.8) |
| Klebsiella pneumoniae 7 (10.0) | Klebsiella pneumoniae 3 (5.9) | |
| Acinetobacter baumannii 6 (8.6) | Acinetobacter baumannii 3 (5.9) | |
| MTBC 6 (8.6) | MTBC 8 (15.7) | |
|
| ||
| Viruses | EBV 11 (15.7) | EBV 4 (7.8) |
| CMV 8 (11.4) | CMV 4 (7.8) | |
| Circovirus 5 (7.1) | Circovirus 3 (5.9) | |
|
| ||
| Fungus | Aspergillus 11 (15.7) | Aspergillus 4 (7.8) |
| Pneumocystis carinii 7 (10.0) | Pneumocystis carinii 3 (5.8) | |
| Rhizopus carinii 4 (5.7) | Actinomyces 2 (3.9) | |
|
| ||
| Atypical pathogen | Mycoplasma 4 (5.7) | Mycoplasma 2 (3.9) |
| Chlamydia 2 (2.9) | Chlamydia 1 (2.0) | |
| Legionellal 1 (2.0) | ||
mNGS, metagenomic next-generation sequencing. MTBC, mycobacterium tuberculosis complex. EBV, Epstein–Barr virus. CMV, cytomegalovirus. ∗Data are presented as no. (%) unless otherwise indicated.